Saturday 17 October 2026 Export UHS’s income statement to Excel — free account

Universal Health Services, Inc.

Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024. In the quarter to June 2026, revenue grew 8.27%, EPS grew 9.47%, free cash flow fell 23.8% and total debt rose 5.87%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.

185.10 2.26 −1.21%

Follow UHS

Alert me

Market cap: $11.0B
P/E: 7.5×
Fwd P/E: 6.1×
Dividend yield: 0.43%
F-score: 8/9
Altman Z: 3.29
Beneish M: −2.45
Dividend safety: 88/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total sells 0.98

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	1	—	—	—	1	—	—	—	—	—	—	—

Insider Ownership 18.22%

Capital & Financial Ratios $m

Market Cap 11,040.00

Revenue 18,114.49

Net Income 1,550.21

Free Cash Flow 845.40

Net Debt 4,713.05

Current Ratio 1.12

Debt/Equity 0.64

P/E ratio 7.45

Fwd P/E 6.12

P/S ratio 0.61

P/B ratio 1.46

Past 5Y EPS Growth 16.02%

This Y EPS Growth 3.76%

Next Y EPS Growth 6.10%

Next Y revenue growth 7.12%

Next 5Y EPS Growth 6.44%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 4.87%

10-year low 10-year high

P/S against its own 10 years 7.30%

10-year low 10-year high

P/B against its own 10 years 11.21%

10-year low 10-year high

EV/Sales against its own 10 years 5.12%

10-year low 10-year high

EV/FCF against its own 10 years 31.71%

10-year low 10-year high

Dividends

Payout Ratio 0.03

Annual Dividend Rate 0.80

Annual Dividend Yield 0.43%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	0.83	0.20 0.20 0.20
2025	0.80	0.20 0.20 0.20 0.20
2024	0.80	0.20 0.20 0.20 0.20
2023	0.80	0.20 0.20 0.20 0.20
2022	0.80	0.20 0.20 0.20 0.20
2021	0.80	0.20 0.20 0.20 0.20
2020	0.20	0.20
2019	0.60	0.10 0.10 0.20 0.20
2018	0.40	0.10 0.10 0.10 0.10
2017	0.40	0.10 0.10 0.10 0.10
2016	0.40	0.10 0.10 0.10 0.10

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	119	126	138	139
Receivables	2,238	2,178	2,602	2,801
Inventory	217	221	232	234
Other	237	292	436	505
	2,811	2,816	3,408	3,679

	2023	2024	2025	Q'26
Payables	614	632	750	2,451
ST’ Debt	127	40	748	772
Other	5	—	—	—
	2,013	2,210	3,240	3,298

Compound Annual Growth %

	10y	5y	3y
Sales	6.74%	8.48%	9.03%
Cash Flow	5.73%	(4.61%)	23.24%
Earnings	8.15%	9.61%	30.18%
Book Value	5.47%	2.77%	7.15%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	4,495	4,638	—	—	—
’25	4,100	4,284	4,495	4,486	17,365
’24	3,844	3,908	3,963	4,114	15,828
’23	3,468	3,548	3,563	3,704	14,282
’22	3,293	3,323	3,336	3,447	13,399
’21	3,013	3,198	3,156	3,275	12,642
’20	2,830	2,730	2,913	3,087	11,559

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	402	443	—	—	—
’25	360	549	381	575	1,864
’24	396	679	333	658	2,067
’23	291	363	162	452	1,268
’22	445	33	221	297	996
’21	72	48	442	322	884
’20	502	949	767	142	2,360

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	184	216	—	—	—
’25	121	283	133	312	849
’24	188	438	85	412	1,123
’23	122	195	(38)	246	525
’22	245	(175)	59	133	262
’21	(176)	(187)	258	132	28
’20	318	779	575	(43)	1,629

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	5.65	5.98	—	—	—
’25	4.80	5.43	5.86	7.06	23.10
’24	3.82	4.26	3.80	4.96	16.82
’23	2.28	2.42	2.40	3.16	10.23
’22	2.02	2.20	2.50	2.43	9.14
’21	2.43	3.79	2.60	3.00	11.82
’20	1.64	2.95	2.82	3.60	10.99

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	99.72	95.26	108.62	114.85	65.20	116.23	82.50	113.69	150.11	152.33	Analyst estimates 2026–2028 Powerpack
	High	139.77	129.74	139.63	157.79	148.27	165.00	158.28	158.57	243.25	246.33
People
People	Employees	75,325	83,100	87,100	90,400	89,000	89,400	93,800	96,700	99,000	101,500
	Revenue/emp, $m	0.13	0.13	0.12	0.13	0.13	0.14	0.14	0.15	0.16	0.17
Income, $m
Income, $m	Revenue	9,766	10,410	10,772	11,378	11,559	12,642	13,399	14,282	15,828	17,365
	Gross margin, %	89.44	89.38	89.15	89.00	88.86	88.71	89.00	89.27	89.97	90.45
	EBT	1,156	1,135	1,035	1,066	1,252	1,293	866	940	1,498	1,972
	EBT margin, %	11.84	10.90	9.60	9.37	10.83	10.23	6.46	6.58	9.46	11.36
	Net income	747	771	798	828	953	988	657	719	1,163	1,511
	Depreciation	417	448	453	490	510	533	582	568	585	619
Per share, $
Per share, $	Revenue	100.47	108.83	115.49	128.19	135.89	153.20	183.26	206.03	237.82	273.11
	Earnings	7.22	7.86	8.35	9.16	11.06	11.99	9.23	10.35	17.16	23.42
	Cash flow	13.72	13.04	13.67	16.21	27.75	10.71	13.62	18.29	31.06	29.32
	Capex	(5.57)	(5.83)	(7.13)	(7.14)	(8.60)	(10.37)	(10.04)	(10.72)	(14.18)	(15.97)
	Free cash flow	8.15	7.21	6.54	9.06	19.15	0.34	3.58	7.57	16.88	13.36
	Book value	47.30	52.81	58.60	62.85	75.26	75.05	81.59	89.39	101.41	115.42
	Shares, m	97	96	93	89	85	83	73	69	67	64
Valuation, ×
Valuation, ×	P/E	14.78	14.71	13.99	15.68	12.41	10.81	15.43	15.10	10.44	9.29
	P/S	1.06	1.06	1.01	1.12	1.01	0.85	0.78	0.76	0.75	0.80
	P/B	2.26	2.19	1.99	2.28	1.83	1.73	1.75	1.75	1.77	1.89
	EV/Sales	1.48	1.44	1.37	1.46	1.24	1.17	1.13	1.09	1.03	1.06
	EV/FCF	18.27	21.77	24.21	20.71	8.80	526.98	57.75	29.80	14.53	21.76
Cash, $m
Cash, $m	Operating cash flow	1,334	1,248	1,275	1,438	2,360	884	996	1,268	2,067	1,864
	Capex	(541)	(558)	(665)	(634)	(731)	(856)	(734)	(743)	(944)	(1,015)
	Free cash flow	792	690	610	804	1,629	28	262	525	1,123	849
Balance, $m
Balance, $m	Working capital	364	(50)	489	353	801	279	623	798	606	168
	Total debt	4,136	4,040	3,999	3,984	3,856	4,190	4,808	4,912	4,505	4,753
	Net debt	4,102	3,966	3,893	3,923	2,632	4,075	4,705	4,793	4,379	4,615
	Shareholders’ equity	4,598	5,051	5,466	5,579	6,402	6,193	5,965	6,197	6,750	7,339
Returns, %
Returns, %	ROA	7.05	7.13	7.07	7.09	7.48	7.46	5.08	5.23	8.03	9.93
	ROIC	9.21	8.87	7.85	8.00	9.40	8.30	5.88	6.68	9.45	10.43
	ROE	15.77	15.59	14.81	14.72	15.71	15.75	11.10	11.80	17.64	21.14

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
THC Tenet Healthcare Corporation	$22.2B	10.3×	6.4×	+14.61% (above 0%: growing)	+212.97% (above 0%: growing)	−43.88% (below 0%: shrinking)	46.78%	24.85%	Compare
EHC Encompass Health Corporation	$12.6B	20.6×	16.8×	+9.58% (above 0%: growing)	+9.93% (above 0%: growing)	−45.01% (below 0%: shrinking)	100.00%	17.85%	Compare
DVA DaVita Inc.	$12.1B	15.0×	13.1×	+5.17% (above 0%: growing)	+56.49% (above 0%: growing)	+49.36% (above 0%: growing)	32.70%	16.29%	Compare
FMS Fresenius Medical Care AG & Co. KGaA	$11.8B	11.5×	12.5×	+3.89% (above 0%: growing)	+6.82% (above 0%: growing)	+1.57% (above 0%: growing)	26.95%	9.58%	Compare
UHS Universal Health Services, Inc.	$11.0B	7.5×	6.1×	+8.27% (above 0%: growing)	+9.47% (above 0%: growing)	−23.78% (below 0%: shrinking)	90.87%	11.14%
ENSG The Ensign Group, Inc.	$10.4B	26.9×	24.1×	+17.33% (above 0%: growing)	+16.22% (above 0%: growing)	+12.24% (above 0%: growing)	16.65%	8.50%	Compare
PACS PACS Group, Inc.	$7.6B	27.6×	16.8×	+9.07% (above 0%: growing)	+45.45% (above 0%: growing)	+220.51% (above 0%: growing)	17.07%	7.66%	Compare
CHE Chemed Corporation	$6.7B	25.7×	20.4×	+8.80% (above 0%: growing)	+42.78% (above 0%: growing)	−43.51% (below 0%: shrinking)	32.90%	13.25%	Compare
CON Concentra Group Holdings Parent, Inc.	$5.0B	24.9×	17.0×	+10.03% (above 0%: growing)	+45.71% (above 0%: growing)	+91.62% (above 0%: growing)	31.70%	18.99%	Compare
Median of peers	$11.1B	22.7×	16.8×	+9.33%	+44.12%	+6.91%	32.20%	14.77%

All 55 Medical Care Facilities stocks →

Universal Health Services, Inc. (UHS) key facts

Strength: Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024.
Strength: Net income was $1.5 billion, or $23.42 per share (basic), a net margin of 8.57%.
Universal Health Services, Inc. (UHS) is a Medical Care Facilities company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, UHS traded at $185.10, a market capitalization of $11.0 billion.
At that price the stock trades at 7.5× trailing-twelve-month earnings and 0.6× sales; its P/E is higher than 5% of its own readings over the past ten years.
Universal Health Services, Inc. pays an annual dividend of $0.80 per share, a yield of 0.43%, with a payout ratio of 3.26%.
Return on equity was 21.1% and debt-to-equity 0.64.
Its Piotroski F-score is 8 out of 9 and its Altman Z-score is 3.29 (safe zone) for fiscal 2025.